81 (72) Bold

bold

Despite heavily promoting the benefits of liquitabs, Bold still lost £8m in value

Already have an account? Sign in here

Want access to this article?

Register for LIMITED access

REGISTER FOR FREE

Get PREMIUM access for £1 a week

SUBSCRIBE NOW